deepull — Series B · €17M

Barcelona Science Park-based DeepUll, which develops culture-free molecular diagnostics for early sepsis detection, announced that Sabadell Asabys had entered its Series B through the new SAHII II fund, taking the round to €17 million in total. Roughly €13 million had been announced in October 2022, with Asabys adding about €4 million in this final close alongside Werfen and the existing syndicate.

LeadSabadell Asabys (Asabys Partners) RoundSeries B Announced1 Mar 2023 CityBarcelona SectorHealthtech & Bio · Medtech / In-vitro diagnostics Source W

Something wrong? Suggest a correction →